Here's how the new-age fintech startup is ensuring credit availability for the underserved sections amid the pandemic
Whether it happens in a year or six months we don't know, but there are enough indicators pointing to a correction
While holistic medicine is being seen as the future of universal healthcare, the two systems should coexist and, if needed, collaborate
To truly prosper in markets, one must learn the power of compounding and you should have patience, says Agarwal
Expect Nifty bank to remain lacklustre, but the pharma index is showing positive traction. The space should be on investors radar, says Jay Purohit
Likhita Chepa of CapitalVia Global Research believes metals and banking sectors will continue to rally further
Nifty has been hovering within the 15,450-15,900 zone for almost a month now and currently trading in the middle of the band
While the near term trend may be subdued, we have advised investors to buy on dips as the long term outlook for gold remains bullish
Even though the phase of easy money making is behind us, markets may come out of the range-bound trade in next 5-10 sessions, says Gautam Shah
There's strong visibility for growth in the auto and pharma space for long term investors, says Kranthi Bathini